Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 50 | 14/07/21 | |
Director of Finance/CFO | 69 | 11/01 | |
Stuart Rich
CTO | Chief Tech/Sci/R&D Officer | 74 | 15/01/21 |
Doug Randall
COO | Chief Operating Officer | - | 14/11/13 |
Douglas Hay
LAW | General Counsel | - | 14/11/13 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Gerry Proehl
CHM | Chairman | 65 | 04/04/14 |
June Almenoff
BRD | Director/Board Member | 67 | 25/02/21 |
Declan Doogan
BRD | Director/Board Member | 72 | 25/02/21 |
Michael Davidson
BRD | Director/Board Member | 67 | 25/02/21 |
Robyn Hunter
BRD | Director/Board Member | 62 | 28/01/22 |
Stuart Rich
CTO | Chief Tech/Sci/R&D Officer | 74 | 15/01/21 |
Chief Executive Officer | 50 | 14/07/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 210 | 0 | 0 | 99,65 % |
Azione B | 1 | 1 958 245 | 1 951 297 ( 99,65 %) | 0 |
Coordinate società
Tenax Therapeutics, Inc.
101 Glen Lennox Drive Suite 300
27517, Chapel Hill
+(919) 855-2100
http://www.tenaxthera.com![Indirizzo Tenax Therapeutics Inc](https://cdn.zonebourse.com/static/address/18045260.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+38,36% | 52,73 Mrd | |
+36,73% | 39 Mrd | |
-8,63% | 38,52 Mrd | |
+25,46% | 30,38 Mrd | |
-11,17% | 26,39 Mrd | |
+11,44% | 26,08 Mrd | |
+45,09% | 14,15 Mrd | |
+32,93% | 12,6 Mrd | |
-5,30% | 11,51 Mrd |